Insiders · Profile

Gangloff Scott A.

SVP, Development & Mfrg at Outlook Therapeutics. Filing since 11 Nov 2016. CIK 0001663253

Company

Date

Role

Action

Amount

Of holding

11 Nov 2016

SVP, Development & Mfrg

Sold, plan not stated

37,369

$140.13K

32.2%

1 decision on file.